Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Ms Young says that some patients find out about trials through their doctor, but it is difficult to reach patients in the greater community. Websites like Myeloma.Trials.com can help patients find trials by disease type and location. There is also MMRF’s Community Gateway, which helps target patients through questions in a survey. She adds that few cancer trails consider the use of placebo drugs. She says phase 3 trials are “no-brainers” for patients.
Dr Kumar adds that clinical trials are important because they will be the future of myeloma treatment. Patients’ awareness of these trials is essential.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen